Iontophoresis — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Iontophoresis is a non-invasive electrotherapy technique that uses a weak direct electrical current to drive charged ions through the skin — either to block eccrine sweat gland function in the treatment of primary hyperhidrosis (excessive sweating) or to deliver charged drug molecules across the skin into underlying tissues without injections. The procedure is one of the most effective non-pharmacological treatments for palmar (hands), plantar (feet), and axillary (armpit) hyperhidrosis, a condition affecting 2–3% of the population that causes significant social and occupational impairment. In tap water iontophoresis for hyperhidrosis — the most widely used application — the patient immerses the affected hands or feet in shallow water-filled trays through which a low-intensity direct current (8–25 milliamperes) is passed. The exact mechanism by which electrical current suppresses sweat gland activity is not fully understood, but current evidence supports blockage of the sweat duct pore at the skin surface by electrically displaced ions and interference with sweat gland cell membrane transport. In drug-delivery iontophoresis, ionised drug molecules (such as anti-inflammatory agents, local anaesthetics, or antibiotics) are driven across the skin by the repulsive force of electrical charge — the same charge repels ions of like polarity, directing them deeper into tissue.

Tap water iontophoresis for hyperhidrosis is indicated for patients with primary hyperhidrosis of the hands, feet, or axillae that has not responded adequately to first-line topical treatments — prescription-strength aluminium chloride antiperspirants (20% or higher concentration), applied at night to dry skin and washed off in the morning, used consistently for 4–8 weeks. Iontophoresis is the preferred second-line treatment for palmar and plantar hyperhidrosis before more invasive options (botulinum toxin injections or surgical sympathectomy). It is not suitable for generalised hyperhidrosis (secondary to systemic disease such as lymphoma, tuberculosis, or menopause) or facial hyperhidrosis — patients with secondary hyperhidrosis should be investigated for the underlying cause. Drug-delivery iontophoresis (using medicated solutions) is used by physiotherapists and sports medicine physicians to treat localised musculoskeletal conditions including plantar fasciitis (dexamethasone iontophoresis), lateral epicondylitis (tennis elbow), calcific tendinitis, and carpal tunnel syndrome. Contraindications for both forms include presence of cardiac pacemakers or implanted electronic devices (direct current interference), metal implants in the treatment area, open skin wounds, eczema or significant skin breakdown, pregnancy, and epilepsy (risk of seizure precipitation in theory, though direct current devices are low-energy).

For palmar/plantar iontophoresis (hyperhidrosis), the patient sits comfortably and immerses both hands (or feet) simultaneously in separate shallow plastic trays — one tray connected to the positive electrode (anode), the other to the negative electrode (cathode) of a battery-powered iontophoresis device. The trays are filled with ordinary tap water (or a sodium bicarbonate solution to buffer acidity). The device is switched on and the current is gradually increased to the patient's comfort level — typically 8–25 mA — over 1–2 minutes. The treatment session lasts 20–30 minutes; current direction may be reversed at the midpoint (polarity reversal reduces skin irritation and distributes ion displacement). Skin should be free from cuts, open sores, or metal jewellery before the session. For medicated iontophoresis (drug delivery), the drug-containing electrode pad (medicated electrode) is placed over the target tissue — such as the plantar fascia for plantar fasciitis — and the return electrode (dispersive) is placed proximally on the same limb. The physiotherapist programmes the device for the appropriate drug type (dexamethasone is negatively charged — delivered via the cathode; lidocaine is positively charged — delivered via the anode), current amplitude (1–4 mA), and dosage (typically 40–80 milliampere-minutes per session). Sessions are performed in physiotherapy clinic 3 times per week for 4–6 weeks.

Tap water iontophoresis for palmar and plantar hyperhidrosis achieves sweat reduction of 70–85% compared with baseline after a standard induction course of 6–10 sessions conducted 3–4 times per week, placing it among the most effective non-invasive treatments for this condition. A 2021 systematic review confirmed significant reductions in sweat production and Hyperhidrosis Disease Severity Scale (HDSS) scores compared with sham treatment, with high patient satisfaction. Published response rates in clinical trials consistently show 70–90% of patients achieving meaningful improvement, with complete cessation of troublesome sweating in 30–40%. Unlike botulinum toxin injections (which require clinic visits, injections, and repeat treatments every 4–6 months at considerable cost), iontophoresis can be performed at home with a portable device after initial clinic training, making it highly cost-effective for long-term management. Home devices (Drionic, Idromed, Hidrex) produce equivalent results to clinic devices. Drug-delivery iontophoresis for plantar fasciitis shows good short-term evidence: dexamethasone iontophoresis achieves significant pain reduction at 4 weeks compared with placebo iontophoresis in randomised trials, with a similar effect size to corticosteroid injections but without the systemic effects or injection-related complications.

Iontophoresis is an extremely safe procedure with a favourable adverse event profile. Skin irritation at the electrode contact site — mild redness (erythema), tingling, dryness, and occasionally vesicle (blister) formation — is the most common side effect, occurring in 30–50% of users during initial sessions, particularly at current amplitudes above 15 mA. Irritation is minimised by applying petroleum jelly (Vaseline) over minor skin cuts before immersion, performing gradual current increases, using polarity reversal during sessions, and applying moisturising cream after each session. Reducing the current amplitude and shortening session duration usually resolves skin irritation. Galvanic burns — thermal skin injury from uneven current distribution — are rare with modern regulated devices and occur when metal objects are inadvertently in the current path or damaged electrode pads produce focal current concentration. Tapwater pH changes during prolonged use cause mild skin acidification at the anode and alkalinisation at the cathode; the addition of sodium bicarbonate (1 teaspoon per litre) buffers this and reduces irritation. There is no systemic absorption of current-carrying ions in quantities that affect systemic physiology. The procedure does not achieve permanent resolution of hyperhidrosis — effect duration after the induction course is typically 2–6 weeks, after which maintenance sessions (1–2 per week) are required indefinitely to sustain sweat suppression.

No recovery period is required after iontophoresis sessions — patients immediately return to all normal activities. Initial results are typically noticeable after 4–6 sessions; full benefit is achieved after 6–10 sessions conducted 3–4 times per week over 2–3 weeks. The treatment protocol is divided into an induction phase (initial intensive sessions to achieve sweat suppression) and a maintenance phase (less frequent sessions — 1–2 per week) to sustain control. Once adequate sweat suppression is achieved, patients extend the interval between sessions to find their minimum effective maintenance frequency — some patients maintain control with one session per week; others require 2–3 sessions weekly. Sessions are performed indefinitely as long as hyperhidrosis requires control. Home devices provide the most practical long-term management strategy, enabling patients to self-treat at convenient times without clinic appointments. Care instructions after sessions: rinse treated skin with clean water, apply a light moisturiser (fragrance-free) to prevent dryness, and protect treated hands or feet from detergents and chemicals for several hours. If significant skin irritation develops, sessions should be paused for 5–7 days until skin heals. Annual review with a dermatologist is recommended to assess treatment response, explore adjunctive treatments (antiperspirants, botulinum toxin), and discuss newer options such as miraDry (microwave-based sweat gland destruction for axillary hyperhidrosis).